These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22537944)

  • 21. Aldosterone as a mediator of severity in retinal vascular disease: Evidence and potential mechanisms.
    Allingham MJ; Mettu PS; Cousins SW
    Exp Eye Res; 2019 Nov; 188():107788. PubMed ID: 31479654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Renin-angiotensin-aldosterone system in thyroid disorders].
    Marcisz C
    Postepy Hig Med Dosw; 2000; 54(4):519-35. PubMed ID: 11016270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aldosterone and angiotensin: Role in diabetes and cardiovascular diseases.
    Patel BM; Mehta AA
    Eur J Pharmacol; 2012 Dec; 697(1-3):1-12. PubMed ID: 23041273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measuring and targeting aldosterone and renin in atherosclerosis-a review of clinical data.
    Hillaert MA; Lentjes EG; Beygui F; Kemperman H; Asselbergs FW; Nathoe HM; Agostoni P; Voskuil M; Ivanes F; Jude B; Bertrand ME; Pasterkamp G; van der Graaf Y; Doevendans PA; Montalescot G; Van Belle E
    Am Heart J; 2011 Oct; 162(4):585-96. PubMed ID: 21982648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heart failure: how important is cellular sequestration? The role of the renin-angiotensin-aldosterone system.
    De Mello WC
    J Mol Cell Cardiol; 2004 Aug; 37(2):431-8. PubMed ID: 15276013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renin-angiotensin system as a potential therapeutic target in stroke and retinopathy: experimental and clinical evidence.
    Fouda AY; Artham S; El-Remessy AB; Fagan SC
    Clin Sci (Lond); 2016 Feb; 130(4):221-38. PubMed ID: 26769658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel interaction between soluble epoxide hydrolase and the AT1 receptor in retinal microvascular damage.
    Wang MH; Ibrahim AS; Hsiao G; Tawfik A; Al-Shabrawey M
    Prostaglandins Other Lipid Mediat; 2020 Jun; 148():106449. PubMed ID: 32360774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The renin-angiotensin system].
    Hilgers KF
    Urologe A; 2009 Aug; 48(8):925-33; quiz 934-5. PubMed ID: 19669119
    [No Abstract]   [Full Text] [Related]  

  • 29. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease.
    Brewster UC; Perazella MA
    Am J Med; 2004 Feb; 116(4):263-72. PubMed ID: 14969655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
    Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Renin-Angiotensin system and vascular disease in diabetes.
    Deinum J; Chaturvedi N
    Semin Vasc Med; 2002 May; 2(2):149-56. PubMed ID: 16222606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The renin-angiotensin-aldosterone system, glucose metabolism and diabetes.
    Giacchetti G; Sechi LA; Rilli S; Carey RM
    Trends Endocrinol Metab; 2005 Apr; 16(3):120-6. PubMed ID: 15808810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of atrial natriuretic factor on blood pressure and the renin-angiotensin-aldosterone system.
    Atlas SA; Volpe M; Sosa RE; Laragh JH; Camargo MJ; Maack T
    Fed Proc; 1986 Jun; 45(7):2115-21. PubMed ID: 2940120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Renin-angiotensin-aldosterone system: the present status and problems].
    Khristov V
    Vutr Boles; 1979; 18(6):8-15. PubMed ID: 392945
    [No Abstract]   [Full Text] [Related]  

  • 35. Renin-angiotensin-aldosterone system in hypertension. The clinical usefulness of measuring components of thisystem.
    Ayers CR
    Va Med Mon (1918); 1969 Jun; 96(6):312-4. PubMed ID: 4308355
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
    J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adrenal renin-angiotensin-aldosterone system in streptozotocin-diabetic rats.
    Nakayama T; Izumi Y; Soma M; Kanmatsuse K
    Horm Metab Res; 1998 Jan; 30(1):12-5. PubMed ID: 9503033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The renin-angiotensin-aldosterone system in congestive failure in conscious dogs.
    Watkins L; Burton JA; Haber E; Cant JR; Smith FW; Barger AC
    J Clin Invest; 1976 Jun; 57(6):1606-17. PubMed ID: 180056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of disease: local renin-angiotensin-aldosterone systems and the pathogenesis and treatment of cardiovascular disease.
    Re RN
    Nat Clin Pract Cardiovasc Med; 2004 Nov; 1(1):42-7. PubMed ID: 16265259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
    Krum H; Gilbert RE
    J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.